Boehringer Ingelheim (Canada) Ltd
562 full-time employees www.boehringer-ingelheim.ca Boehringer Ingelheim (Canada) Ltd. is a pharmaceutical company that offers development and manufacturing services. · Offers its new moms leave top-up payments to 100% of salary for the first six weeks, supplemented by a 90% top-up for the remaining 11 weeks of their maternity leaves.
Boehringer Ingelheim Canada is one of the world’s leading pharmaceutical companies. Founded more than 130 years ago by Albert Boehringer, the family-owned company is driven to find new and better ways of improving the health of humans and animals. “We are honoured to be recognized as one of the Top Employers in Hamilton-Niagara,” said Richard Mole, President and CEO of Boehringer Ingelheim (Canada) Ltd. “Every day, our colleagues help improve the health of Canadian patients. This award reflects the value we place on our employees and the work they do.” Among its approximately 600 employees across Canada, Boehringer Ingelheim nurtures a diverse, collaborative and open environment that attracts people of exceptional character and ability. In 2017, the company introduced Our FOCUS –a framework that defines who they are, how they work and what they want to achieve – to guide its actions and help employees concentrate their efforts where they’re needed most. Boehringer Ingelheim believes its success rests on the power of its people to create value for customers through innovation. Our FOCUS defines three qualities (AAI) integral to this formula: • Accountability to demonstrate ownership for decisions and actions • Agility to quickly act, with an open mind, to face internal and external transformation • Intrapreneurship to generate innovative ideas, together with customers, that respond to changing markets
Our FOCUS is embedded in the company’s culture, systems and programs. Its approach to people helps all colleagues grow through performance management and a robust learning environment. Those who live and work AAI benefit professionally, as well as financially, thanks to a rewards system based on the principle that we work together and we win together. Development opportunities are linked to AAI and employees are supported throughout their careers, whether moving into new roles, expanding within existing roles or moving cross functionally. “We are proud of the company culture our colleagues have built. We provide support to our employees and local communities based on our core values of trust, respect, empathy and passion,” said Mole. The Canadian headquarters of Boehringer Ingelheim is located in Burlington, Ontario. Locally, the company conducts and sponsors clinical trials to establish safety and efficacy of the medicines it develops. Since 2000, the company has run 215 clinical trials in Canada, across numerous therapeutic areas including respiratory, cardiometabolic, oncology, neurology, immunology and inflammation. Boehringer Ingelheim’s animal health division prides itself on providing innovative solutions that prevent and reduce disease, and improve the health and quality of life for animals.
“We are proud of the company culture our colleagues have built. We provide support to our employees and local communities based on our core values of trust, respect, empathy and passion.” --- Richard Mole, President & CEO, Boehringer Ingelheim (Canada) Ltd.